Clinical Trials on HR+/HER2- 乳腺癌 in Canada
总计831个结果
-
Ohio State University Comprehensive Cancer Center招聘中
-
Ontario Clinical Oncology Group (OCOG)完全的
-
Ottawa Hospital Research Institute主动,不招人
-
Ontario Clinical Oncology Group (OCOG)Cancer Care Ontario完全的III 期乳腺癌(T0N2、T1N2、T2N2、T3N1、2 或 T4) | IIb 期乳腺癌 (T3N0)加拿大
-
Jewish General HospitalQuebec Breast Cancer Foundation招聘中
-
MacroGenics完全的HER-2阳性乳腺癌 | 转移性肿瘤美国, 西班牙, 意大利, 加拿大, 以色列, 比利时, 德国, 捷克语, 奥地利, 大韩民国, 丹麦, 英国, 葡萄牙, 法国, 波兰, 荷兰, 芬兰, 波多黎各
-
CHU de Quebec-Universite LavalQuebec Breast Cancer Foundation完全的
-
Canadian Cancer Trials GroupUniversity Health Network, Toronto; AstraZeneca主动,不招人
-
Ottawa Hospital Research Institute完全的
-
Ottawa Hospital Research InstituteGlaxoSmithKline; Hamilton Health Sciences Corporation; London Regional Cancer Program, Canada; Ontario...完全的
-
AHS Cancer Control AlbertaCanadian Institutes of Health Research (CIHR); University of Alberta未知
-
Ottawa Hospital Research InstituteCanadian Breast Cancer Foundation完全的
-
Dr. Sarkis Meterissian完全的
-
Sunnybrook Health Sciences CentreCanadian Breast Cancer Foundation完全的
-
University Health Network, TorontoSusan G. Komen Breast Cancer Foundation; Dr. Julia Knight (research collaborator)完全的
-
University Health Network, TorontoUnited States Department of Defense完全的
-
University Health Network, TorontoOntario Ministry of Health and Long Term Care; Canadian Breast Cancer Research Alliance完全的
-
McMaster UniversityCanadian Breast Cancer Foundation完全的
-
Sunnybrook Health Sciences CentreTerry Fox Research Institute尚未招聘
-
University Health Network, TorontoMarkham Stouffville Hospital招聘中